MicrobiologybioRxiv
Oral Hsp90 inhibitor, SNX-5422, attenuates SARS-CoV-2 replication and dampens inflammation in airway cells.
R. Goswami, V. S. Russell, J. J. Tu…·S. R. Permar
This study shows that the Hsp90 inhibitor SNX-5422 reduces SARS-CoV-2 replication and inflammation in airway cells, suggesting its potential as an early therapeutic.
DOI 10.1016/j.isci.2021.103412